TurnerTrends Stock Rating Report for CADX
Data valid for week beginning July 21, 2008
|
CADX [News]
|
Cadence Pharmaceuticals Inc
|
Company Profile
"Cadence Pharmaceuticals, Inc., a biopharmaceutical development stage company, focuses on in-licensing, developing, and commercializing proprietary product candidates for use in the hospital setting in the United States and Canada. The company has two Phase III products in development, which include Acetavance, an intravenous formulation of acetaminophen that is used for the treatment of acute pain and fever, which are in-licensed under the brand name Perfalgan in Europe- and Omigard, an omiganan pentahydrochloride aqueous gel for the prevention and treatment of device-related, surgical wound-related, and burn-related infections that is in-licensed in North America and Europe. Cadence Pharmaceuticals, Inc. was founded in 2004 and is headquartered in San Diego, California."
|
Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
|
|
|
Want to take a more "hands off" approach to investing with TurnerTrends? Try our managed accounts and hedge fund at Sabinal Capital Investments
|
|
Latest News
| Tue, 17 Jun 2008 20:30:00 Etc/GMT | Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York (PR Newswire) | | Wed, 4 Jun 2008 20:36:00 Etc/GMT | Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York (PR Newswire) | | Mon, 26 May 2008 23:06:12 Etc/GMT | Cadence Pharmaceuticals, Inc. Q1 2008 Earnings Call Transcript (at Seeking Alpha) | | Fri, 9 May 2008 10:04:57 Etc/GMT | CADENCE PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (EDGAR Online) | | Wed, 7 May 2008 16:30:45 Etc/GMT | New Star Analyst Rankings for CADENCE PHARM. INC. (StarMine) | | Tue, 6 May 2008 12:05:24 Etc/GMT | CADENCE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a (EDGAR Online) | | Tue, 6 May 2008 12:00:00 Etc/GMT | Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update (PR Newswire) | | Tue, 6 May 2008 11:07:51 Etc/GMT | Q1 2008 CADENCE PHARMACEUTICALS INC Earnings Release - Before Market Open (CCBN) | | Wed, 30 Apr 2008 21:06:00 Etc/GMT | Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter Financial Results and Provide a Clinical Program Update on May 6, 2008 (PR Newswire) | | Wed, 30 Apr 2008 20:57:00 Etc/GMT | Cadence Pharmaceuticals' CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2008 (PR Newswire) | | Fri, 21 Mar 2008 16:50:18 Etc/GMT | CADENCE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online) | | Thu, 20 Mar 2008 13:04:50 Etc/GMT | CADENCE PHARMACEUTICALS INC Financials (EDGAR Online Financials) | | Thu, 13 Mar 2008 21:00:51 Etc/GMT | CADENCE PHARMACEUTICALS INC Files SEC form 10-K, Annual Report (EDGAR Online) | | Wed, 12 Mar 2008 20:05:55 Etc/GMT | CADENCE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition (EDGAR Online) | | Fri, 15 Feb 2008 13:31:22 Etc/GMT | CADENCE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online) | | Mon, 4 Feb 2008 11:03:15 Etc/GMT | CADENCE PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure (EDGAR Online) | | Fri, 11 Jan 2008 21:53:51 Etc/GMT | Friday's Health Winners & Losers (at TheStreet.com) | | Fri, 11 Jan 2008 21:46:33 Etc/GMT | CADENCE PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure (EDGAR Online) | | Fri, 11 Jan 2008 18:50:51 Etc/GMT | Cadence Shares Hurt by Pain Drug Trial (at TheStreet.com) | | Mon, 17 Dec 2007 21:30:14 Etc/GMT | CADENCE PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (EDGAR Online) | News provided by Yahoo! Finance |
|
